1. Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome 
Franca Fruzzetti, M.D., Daria Perini, M.D., Veronica Lazzarini, M.D., Donatella Parrini, M.D., Marco Gambacciani, M.D., Andrea Riccardo Genazzani, M.D. 
Fertility and Sterility 
Volume 94, Issue 5, Pages (October 2010)
DOI: /j.fertnstert
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

2. Figure 1
Changes in clinical characteristics and in the lipid profile of patients with PCOS submitted to treatment with DRP/EE20 alone or combined with metformin or CPA for 6 months. Data are expressed as means ± SD. The Wilcoxon test was performed to evaluate the differences in the response to each treatment in each group. P<.05 was considered statistically significant. aP<.01 vs. baseline value in the DRP/EE20 plus CPA group; bP<.05 vs. baseline value in the DRP/EE20 plus metformin group.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

3. Figure 2
Changes in index of glucose tolerance and insulin sensitivity in patients with PCOS treated with DRP/EE20 alone or combined with metformin or CPA for 6 months. Data are expressed as means ± SD. The Wilcoxon test was performed to evaluate the differences in the response to each treatment in each group. P<.05 was considered statistically significant. aP<.01 vs. baseline value in the DRP/EE20 + CPA group; bP<.05 vs. baseline value in the DRP/EE20 + metformin group; cP<.005 vs. baseline value in the DRP/EE20 + CPA group; dP<.001 vs. baseline value in the DRP/EE20 + CPA group; eP<.05 vs. baseline value in the DRP/EE20 group; fP<.01 vs. baseline value in the DRP/EE20 group. AUC = AUC during OGTT.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions

4. Figure 3
Changes in serum androgen profile of patients with PCOS treated with DRP/EE20 alone or combined with metformin or CPA for 6 months. Data are expressed as means ± SD. The Wilcoxon test was performed to evaluate the differences in the response to each treatment in each group. P<.05 was considered statistically significant. aP<.01 vs. baseline value in the DRP/EE20 + CPA group; bP<.05 vs. baseline value in the DRP/EE20 + metformin group; cP<.005 vs. baseline value in the DRP/EE20 + CPA group; dP<.001 vs. baseline value in the DRP/EE20 + CPA group; eP<.05 vs. baseline value in the DRP/EE20 group; fP<.01 vs. baseline value in the DRP/EE20 group; gP<.001 vs. baseline value in the DRP/EE20 group; hP<.001 vs. baseline value in the DRP/EE20 + metformin group.
Fertility and Sterility  , DOI: ( /j.fertnstert )
Copyright © 2010 American Society for Reproductive Medicine Terms and Conditions